awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28068710-237F6D21-21AF-4A9B-B384-1964B28FB69F
Q28068710-237F6D21-21AF-4A9B-B384-1964B28FB69F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28068710-237F6D21-21AF-4A9B-B384-1964B28FB69F
Tyrosine kinase inhibitors: friends or foe in treatment of hepatic fibrosis?
P2860
Q28068710-237F6D21-21AF-4A9B-B384-1964B28FB69F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28068710-237F6D21-21AF-4A9B-B384-1964B28FB69F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2129df231cc07a310ea65de857e71b5c6402b89e
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr